Skip To Main Content
Biotherapeutic Glycoengineering on Muck Rack

Biotherapeutic Glycoengineering

As seen in: Oxford Academic
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Biotherapeutic

Contact Biotherapeutic, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Novel genetically glycoengineered human dendritic cell model reveals regulatory roles of α2,6-linked sialic acids in DC activation of CD4 + T cells and response to TNFα

|
By Søltofts Plads, Biotherapeutic Glycoengineering, Kaylin Elisabeth
| Oxford Academic Verified
Dendritic cells (DCs) are central for the initiation and regulation of appropriate immune responses. While several studies suggest important regulatory roles of sialoglycans in DC biology, our understanding is still inadequate primarily due to a lack of appropriate models. Previous approaches based on enzymatic- or metabolic-glycoengineering and primary cell isolation from genetically modified mice have limitations related to specificity, stability, and species differences.
Open in Who Shared Issue with article?
See all 1 articles